<p>Yselty is a medicine used in adult women of childbearing age to treat:</p><ul><li>moderate to severe symptoms of uterine fibroids, which are non-cancerous (benign) tumours of the womb (uterus);</li><li>symptoms of endometriosis, a condition where tissue similar to the endometrium (the lining of the womb) grows outside the womb. It is used in women who have already had treatment for this condition.</li></ul><p>Yselty contains the active substance linzagolix choline.</p>
Therapeutic Indication
<div class="subsection mt-3-5"> <h3>Therapeutic indication</h3><p>Yselty is indicated in adult women of reproductive age for: <br>- treatment of moderate to severe symptoms of uterine fibroids,<br>- symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis (see section 5.1).</p></div>
Therapeutic Area (MeSH)
ATC Code
H01CC04
ATC Item
N/A
Pharmacotherapeutic Group
Pituitary and hypothalamic hormones and analogues
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| linzagolix choline | N/A | linzagolix choline |
EMA Name
Yselty
Medicine Name
Yselty
Aliases
N/ANo risk management plan link.
